Results 1 -
1
of
1
for
DINUTUXIMAB
- ... trial, the FDA approved the antibody therapy drug dinutuximab for high-risk neuroblastoma. The drug binds to ... the trial who received two transplants, followed by dinutuximab, lived substantially longer without their cancer progressing. Childhood ...